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A B S T R A C T
Background: For medium and large coronary artery ﬁstula (CAF), the initially selected device sometimes
has to be exchanged by reconstruction of track wire loop due to the complexity of CAF.
Objectives: We sought to evaluate the feasibility and safety of transcatheter closure of medium and large
CAF by using the wire-maintaining technique (WMT).
Methods: A total of 18 patients aged 15–56 years with congenital CAF underwent percutaneous
transcatheter closure by WMT between April 2006 and October 2012. The immediate and long-term
outcomes were evaluated.
Results: Of the 18 patients (11 females), 16 (88%) underwent successful transcatheter closure of ﬁstula
using WMT. The CAFs originated from the right coronary artery (67%), the left circumﬂex coronary artery
(28%), and the left anterior descending coronary artery (5%). The drainage sites were the right ventricle
(56%), right atrium (22%), left ventricle (11%), and coronary sinus (11%). The mean diameter of ﬁstulas
was 9.5  1.71 mm and mean size of the devices was 13.6  3.03 mm. An angiogram following device
deployment showed complete occlusion in 11 patients, mild residual shunt in 2 patients, and trivial residual
shunt in 3 patients. One patient had transient ST–T wave changes, and one patient had hemolysis after the
procedure. Follow-up ranged from 1 month to 54 months (median 39 months). Echocardiogram showed
trivial residual shunt in 3 patients at 6-month follow-up and in 1 patient at 12-month follow-up. Coronary
artery thrombosis was observed in 1 patient by multislice computed tomography at 12-month follow-up.
Conclusion: For those patients with medium and large complex ﬁstula, transcatheter closure of CAF can
be performed by using the wire-maintaining technique.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Congenital coronary artery ﬁstula (CAF) is an abnormal
communication between an epicardial coronary artery and a
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[1–3]. Similar to other congenital heart diseases [4], typical CAFs
are often asymptomatic during childhood but adult patients are
usually symptomatic. When symptomatic, the most common
ﬁndings are heart failure secondary to volume overload resulting
from left to right shunting, ischemia secondary to coronary steal,
arrhythmia, ﬁstula rupture or thrombosis, and infective endocar-
ditis [5]. Medium and large ﬁstulas generally are required to close
to prevent these complications. Traditionally, surgical closure has
been standard treatment of CAF. In 1983, Reidy et al. [6] ﬁrst
reported transcatheter closure of CAF which has become an
alternative to surgical closure. The advantages of the transcatheter
approach include less morbidity, lower cost, shorter recovery time,
and avoidance of thoracotomy and cardiopulmonary by-pass
[7]. Larger devices are usually required for closure of large to reserved.
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through the ﬁstula [8]. Sometimes the initially selected device is
inappropriate for the complexity of CAF. In order to change the
device, the interventional cardiologist has to reconstruct the
arteriovenous wire loop and reintroduce the delivery sheath,
which prolongs the procedural time and increases the risk of
complications. Recently a novel wire-maintaining technique
(WMT) used in transcatheter closure of perimembranous ventric-
ular septal defect was reported [9] to avoid the reconstruction of
arteriovenous wire loop in patients requiring device replacement.
We describe our experience with percutaneous treatment of
medium and large CAF in 18 patients between 2006 and 2012 using
WMT.
Methods
Patients
From April 2006 to October 2012, 18 patients (11 females) with
medium and large CAF underwent transcatheter ﬁstula closure,
while those with additional complex cardiac defects requiring
surgical management or with tiny CAF found incidentally during
catheterization were excluded from the study. All patients
underwent cardiac evaluations including history, physical exami-
nation, laboratory, and electrocardiogram (ECG). Written informed
consent was obtained from all patients or their guardians prior to
the procedure. Changhai Hospital institutional review board
approved the present retrospective review.
Devices
Amplatzer Vascular plug and Amplatzer Vascular Plug II (AGA
Medical, Golden Valley, MN, USA) and patent ductus arteriosus
occluder, plug and double-disk occluder of muscular ventricular
septal defect (Shanghai Shape Memory Alloy Ltd., Shanghai, China)
were used. It had been explained to patients before treatment that
Amplatzer Vascular plug is a safe and effective device that has been
used in closure of CAF, although it does not have indication for
cardiac lesions by the US Food and Drug Administration.
Procedure
Heparin was administered (100 units/kg) after the femoral
venous and arterial accesses were established. After hemodynamic
data were obtained, aortic root angiography and selective coronary
angiography were performed to demonstrate the anatomy of the
ﬁstula, its drainage site, and identify distal coronary branches.
Feasibility and approach to closure were determined by the
number and location of drainage sites, the location of the proximal
coronary branches, and the ability to cannulate the distal part of
the ﬁstula. To access the ﬁstula, guiding catheter including Judkins
Left, Judkins Right, extra-backup XB (Cordis, Juarez, Mexico) and
0.035-inch super smooth guidewire (Terumo, Tokyo, Japan) were
used. Devices were deployed either via the femoral artery or
femoral vein, using a track wire loop (via femoral artery and
femoral vein). The WMT reported previously [9] was used during
the procedure. In brief, the track wire loop was maintained in the
delivery sheath during the occluder insertion and deployment.
Even if the initial occluder was inappropriate, the delivery sheath
could be reintroduced over the maintained wire after withdrawal
of the occluder, and the reconstruction of track wire loop was
avoided (Fig. 1). Devices were selected by the operator based on the
size and other characteristics of the ﬁstula. During temporary
occlusion at the proposed site of device deployment, ECG was
monitored for up to 15 min to assess for ischemia. After the
appropriate size and proper position of the occluder wereconﬁrmed by coronary angiogram, the track wire was then
withdrawn gently from the femoral artery by ﬁxing the push
rod and delivery sheath. Finally, with conﬁrmation of normal
echocardiographic and ECG parameters, the device was released.
Selective coronary angiography was performed immediately after
device deployment to assess the presence of residual shunt. The
degree of residual shunt was deﬁned as trivial (shunt <1 mm),
mild (1–2 mm), moderate (3–4 mm), and severe (>4 mm).
Postoperatively patients without further complications received
aspirin (3–5 mg/kg) or warfarin based on the size of CAF for
6 months.
Follow-up
ECG, echocardiogram, and chest radiograph were performed
24 h after the procedure. Each patient who underwent successful
CAF closure was followed up clinically by ECG and echocardiogram
at 1, 3, 6, and 12 months. A residual shunt was considered to be
present if color-Doppler ﬂow mapping showed a shunt. It was
classiﬁed as follows: trivial (1 mm color jet width), mild (1–2 mm),
moderate (2–4 mm), or large (4 mm). Multislice computed
tomography (MSCT) was performed at 12 months.
Data analysis
Continuous variables are reported as mean  SD or median and
range, as appropriate. For proportions, numbers and percentages are
used. Statistical analysis was performed using SPSS version 17.
Results
Of 18 patients, 16 underwent successful CAF closure by using
WMT and occluders were exchanged in 5 patients. Two patients
had unsuccessful procedures due to extreme vessel tortuosity
with inability to cannulate the distal ﬁstula. At the time of
operation, the mean age was 30.7  10.9 years (range, 15–56
years). Details of the patients are shown in Table 1. The most
common symptoms were exertional dyspnea in 9 patients, chest
pain in 3 patients, and heart failure in 1 patient. A continuous
systolic–diastolic murmur was present in 13 patients. All patients
received antiplatelet therapy before intervention. ECG showed left
ventricular hypertrophy in 2 patients and nonspeciﬁc ST- and
T-wave changes in 4 patients. CAF origin and drainage site are
shown in Table 1. Origin from the right coronary artery (RCA) was
the most common origin, followed by the circumﬂex artery, and the
left anterior descending coronary artery. The ﬁstula drained most
commonly into the right ventricle. There was no signiﬁcant
atherosclerotic disease noticed in the coronary arteries.
The mean diameter of the ﬁstulas was 9.5  1.71 mm, and the
mean size of devices was 13.6  3.03 mm (Table 1). Immediate post-
deployment angiography documented complete occlusion in
11 patients, mild residual ﬂow in 2 patients, and trivial residual
ﬂow in 3 patients. The ﬂuoroscopy time was 25.4  6.4 min and the
procedure time was 96.3  24.6 min. There were transient ST-T wave
changes during positioning of the delivery sheath that resolved
following withdrawal of the sheath. Transient hemolysis occurred in
1 patient (#14) with a large distal-type ﬁstula from RCA to left
ventricle and treated with a 12-mm double umbrella device (double-
disk occluder of muscular ventricular septal defect) with mild
residual shunt by angiogram and who was successfully treated with
intravenous infusion of normal saline and dexamethasone (10 mg
daily) and oral sodium bicarbonate to prevent acute kidney injury
without blood transfusion and recovered a week later. He did not
receive antiplatelet therapy postoperatively.
Follow-up ranged from 1 month to 54 months (median
39 months). At the 1-, 3-, 6-month and 1-year follow-up
Fig. 1. Transcatheter closure of a large congenital coronary artery ﬁstula using wire-maintaining technique. (A) Ascending aortogram in right anterior oblique (RAO)
projection showing a large coronary artery ﬁstula from right coronary artery (RCA) to left ventricle (LV). There was a narrowing (white arrow) in the ﬁstula proximal to the
connection to the LV. (B) Formation of a track loop with a super smooth guidewire through the ﬁstula to the ascending aorta. The wire was caught in a snare advanced from the
contralateral femoral artery and then exteriorized creating a smooth wire loop. After a contralateral femoral arteriogram was performed, the guiding catheter was introduced
over the wire loop across the ﬁstula, and the delivery sheath (12F) was advanced into the distal ﬁstula from the LV aspect. (C) The track wire was maintained and a 14-mm
occluder of muscular ventricular septal defect was initially deployed, the disk of occluder protruded into ﬁstula, indicating the occluder was too large. (D) The other 12-mm
occluder of muscular ventricular septal defect was exchanged into the sheath and deployed over the maintaining wire loop. The waist of occluder was placed at the ﬁstula
narrowing. After ﬁstula was closed with mild residual shunt by selected coronary angiogram of RCA via the guiding catheter, the wire loop and guiding catheter were
withdrawn together. Ascending aortogram via a pigtail catheter showed ﬁstula was occluded with mild residual shunt. (E) With conﬁrmation of echocardiographic and
electrocardiographic parameters, the device was released. (F) Cine angiographic image of the occluder released in anteroposterior projection.
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with no clinical murmurs. ECG showed no ST-T waves changes.
During 6-month follow-up, echocardiogram showed normal wall
motion in all patients and trivial residual ﬂow in 3 patients. At
1-year follow-up, echocardiogram showed trivial residual ﬂow inTable 1
Clinical characteristics and interventional data of patients who underwent coronary ar
Patient
number
Age in
years/sex
Symptoms CAF
origin
CAF
drainage
CAF size
(mm)
1 27/F AS LCX RV 8.9 
2 36/F Dyspnea RCA RA 10.1 
3 56/M heart failure RCA RV 11.8 
4 17/F Dyspnea RCA RV 7.1 
5 36/M Dyspnea LAD RV 8.4 
6 28/F Dyspnea RCA RV 8.6 
7 18/M Dyspnea LCX RA 7.6 
8 29/F AS RCA RA 11.7 
9 21/F Dyspnea LCX RV 8.3 
10 42/F chest pain RCA RV 9.6 
11 39/F Dyspnea RCA LV 13.1 
12 31/F Dyspnea RCA RA 8.5 
13 46/M chest pain LCX CS 9.8 
14 22/M AS RCA LV 10 
15 15/M AS RCA RV 9.7 
16 23/F Dyspnea RCA RV 11.9 
17 36/F Chest pain RCA CS 7.4 
18 30/M AS LCX RV 8.2 
CAF, coronary artery ﬁstula; AS, asymptomatic; AVP, Amplatzer vascular plug; echo, ech
coronary artery; LCX, left circumﬂex coronary artery; LV, left ventricle; PDA, patent duc
right ventricle; VSD, ventricular septal defect.1 patient. There were no deaths, myocardial infarction, signiﬁcant
arrhythmias, strokes, infections, device migration, or ﬁstula
dissection.
At the 12-month follow-up, MSCT obtained in 10 patients
showed that no patients had recanalization, all devices retainedtery ﬁstula closure.
CAF type Qp/Qs Device/size (mm) RS by
angiogram
RS by
echo
Distal 1.4/1 PDA occluder/12 None None
Proximal 1.6/1 PDA occluder/14 None None
Proximal 1.6/1 AVP/16 None None
Distal 1.4/1 PDA occluder/10 None None
Distal 1.5/1 AVP/12 None None
Proximal 1.5/1 PDA occluder/12 None None
Proximal 1.4/1 Muscular VSD occluder/10 None None
Proximal 1.7/1 PDA occluder/18 Trivial Trivial
Distal 1.4/1 muscular VSD occluder/10 None None
Proximal 1.5/1 PDA occluder/14 None None
Proximal – PDA occluder/20 Trivial None
Proximal 1.4/1 PDA occluder/12 None None
Proximal – AVPII/14 Mild Trivial
Distal – Muscular VSD occluder/12 Mild None
Proximal 1.5/1 PDA occluder/14 None None
Distal 1.6/1 Plug/18 Trivial Trivial
Proximal 1.3/1 Failed – –
Distal 1.4/1 Failed – –
ocardiography; HF, heart failure; CS, coronary sinus; LAD, left anterior descending
tus arteriosus; RA, right atrium; RCA, right coronary artery; RS, residual shunt; RV,
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anticoagulation therapy because of hemolysis after procedure had
thrombosis of the ﬁstula segment leaving a short stump at its
origin from the aorta without symptoms (Fig. 2D–F). He was
treated with warfarin and thrombus did not extend to the proximal
of RCA at 1-year follow-up by echocardiography. Coronary main or
branch occlusion was not observed in other patients.
Discussion
Transcatheter closure of CAF has become an alternative to
surgical closure. It was ﬁrst reported by Reidy et al. [6] in
1983. Over the years, there has been a series of studies about
transcatheter closure of CAF. Various devices including detachable
coils [10], Amplatzer vascular plug [11], Amplatzer duct occlude
[8], and covered stents [12] were used, while the vast majority of
the ﬁstulas were closed using microcoils. For medium and large
ﬁstulas, interventional occlusion with coils is technically demand-
ing and time consuming [13]. Using larger devices alternatively
might be an appropriate choice. Sometimes the initially selected
device and position for the device to be implanted might not be
optimal because of the complexity of CAF. Device replacement was
routinely required by re-establishing the arteriovenous loop to
exchange the occluder. It could lead to prolonged procedure time
and increase the risk of complications including arrhythmia, and
injuries of valves and vessels. Therefore, WMT was used to avoid
the reconstruction of arteriovenous wire loop [9]. To the best of our
knowledge, this is the ﬁrst report about transcatheter closure of
medium and large CAF using WMT. Compared with the conven-
tional technique, it is associated with shortened procedure and
ﬂuoroscope time [8,14,15]. Compared with transarterial approach
including retrograde approach and guide-in-guide approach, WMT
shows many advantages, including avoiding potential damage toFig. 2. Three-dimensional computed tomography scan of 2 patients. At 12-month follow
no recanalization of coronary artery ﬁstula and devices retained optimal shapes with a sta
coronary artery (RCA) (black arrow). (D–F) Thrombus (yellow arrow) had formed in ththe femoral artery, coronary artery, and ﬁstula vessel, allowing use
of a larger delivery sheath and a larger device, and offering an
approach to close the tortuous ﬁstula. However, this technique is
more difﬁcult to perform and needs skilled operators. In our study,
replacement of devices was mainly caused by inappropriate
position for the device, and unsuitable size and shape of devices for
the anatomic morphology of ﬁstulas.
The device was supposed to be deployed as distal as possible in
the vessel, to avoid occlusion of proximal coronary branches
[16]. The type of device should be selected based on the ﬁstula
morphology. If the location where the devices were deployed had a
local narrow part, a double umbrella device should be selected in
order to prevent migration. And if it looked like tubular (had not an
obvious narrow part), the occluder of the patent ductus arteriosus
should be suitable. It is difﬁcult to determine appropriate size of
device due to the variation of morphology of the ﬁstula. Under-
sizing of the device may lead to residual shunt and device
migration [14]. In our experience, for the tubular occluder, the
device selected requires a 30–50% oversize to be stable in the
vessel, and for the double umbrella device 20–30% oversize is
appropriate.
In order to reduce complications using WMT during procedure,
several details should be noticed. Firstly, in patients with large
ﬁstula, the preferred size of delivery sheath should be slightly
larger (1 French) than expected. Larger sheath could allow the
device to pass easily while maintaining the wire in it, avoiding
repeatedly changing delivery sheath and injuring the venous
system. If the device insertion was still difﬁcult, what is needed is
not to replace with a larger sheath, but to withdraw the maintained
wire. Secondly, before the device deployment, the shape, size and
position of occluder should be conﬁrmed by coronary angiography
via the guiding catheter which has been used to create the track
loop. The residual shunt could be assessed by transthoracic-up, three-dimensional computed tomography scan of 2 patients showed there was
ble position (asterisk) (A–F). (A–C) No thrombus in the proximal cul-de-sac off right
e proximal cul-de-sac off RCA (black arrow).
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is thin and ﬂexible which could not lead to residual shunt. Thirdly,
the coronary guiding catheter should be introduced over the track
loop from the femoral artery and its tip should kiss with the
occluder before withdrawing the maintained wire track so as to
avoid the injury of the ﬁstula and coronary artery. Fourthly, the
closure device should not be released until the proper size and
position of occluder were conﬁrmed by coronary artery angiogra-
phy, and the residual shunt and damage of heart valves were
excluded by transthoracic echocardiography.
One patient was found to have thrombosis of coronary by MSCT
at 12-month follow-up. There are limited and incomplete data
[10,17–19] regarding the coronary artery thrombosis after closure
of ﬁstula. The exact mechanism of thrombus formation either
surgically or percutaneously is unknown, but it seems reasonable
to speculate that the substantial reduction in coronary ﬂow down
the aneurysmal vessel was a signiﬁcant contributory factor.
Whether these patients should receive either antiplatelet or
anticoagulation therapy before and after the procedure is not clear.
Patients with large distal-type CAF and severely dilated proximal
feeding or conduit coronary artery may be at increased risk of
thrombosis after closure [16,19]. Considering stasis of ﬂow might
occur with successful closure of ﬁstula, oral antiplatelet or
anticoagulation therapy after procedure is essential [20]. The
duration of antiplatelet or anticoagulant therapy is unclear but it is
reasonable to continue at least for 4 weeks and perhaps longer
[10]. In our series, all patients received aspirin before catheteriza-
tion. Considering the large size of ﬁstula, antiplatelet or antic-
oagulation therapy (aspirin or warfarin) was given after procedure
for 6 months except for one patient with large distal-type ﬁstula
from RCA to left ventricle who had mild residual shunt after device
deployment by angiogram and had hemolysis the day after the
procedure. It has been speculated the residual shunts are more
common when occluder is used in high-pressure, high-ﬂow
locations. We assumed that residual shunt was the major cause
of hemolysis. The antiplatelet or anticoagulation therapy was not
administered which favored clot formation. However, thrombosis
of coronary occurred in the patient without symptoms by MSCT
12 months later. He was administered warfarin to prevent
extension of thrombus. Therefore, those patients with larger
ﬁstula without antiplatelet or anticoagulation therapy because of
complications after procedure should be followed up closely. The
antiplatelet or anticoagulation therapy should be given as soon as
possible. There are limited data about use of aggressive antic-
oagulation strategy post closure of large distal CAF, such as heparin
24–48 h followed by warfarin for 3–6 months, which might induce
residual shunt.
Although transcatheter closure of CAF using wire-maintaining
technique is safe and feasible, there are some limitations. To
maintain wire, a larger delivery sheath is usually needed which
increases the risk of complications such as injury to vessels, ﬁstula,
and valves. Therefore, it is important that experienced operators
perform this procedure in appropriately selected patients.
Additionally, in the clinical follow-up of our study, recatheteriza-
tion was not performed in all patients, since it is invasive. Coronary
angiography has the advantage of showing evidence of remodel-
ing, coronary branch occlusion with collateral ﬂow along with
diastolic function. This is important to further evaluate which
patients are at high risk for coronary events.
Conclusion
For those patients with medium and large anatomically suitable
ﬁstula, transcatheter closure of CAF using WMT is feasible and safe.Due to the fact that a larger delivery sheath is needed during the
procedure, a skilled operator is required. For those ﬁstulas that
might be closed by the initially selected occluder the routine
method is recommended. Patients with medium or large CAF
should be given antiplatelet or anticoagulation therapy before and
after procedure to prevent thrombosis.
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